Trial Profile
A phase II trial of natural killer cell therapy in combination with rituximab in patients with B-cell malignant lymphoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy (Primary)
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 02 Mar 2016 New trial record